PSMA3 and Miyoshi myopathy: Kaplan-Meier analysis showed that high levels of PSMA3 in CD138+ MM cells correlated with decreased progression-free survival and overall survival in patients with MM, and high levels of PSMA3 could also serve as an independent prognostic factor for patients with MM receiving bortezomib treatment.